| JHJIX | RWEBX | JHJIX / RWEBX | |
| Total Expense Ratio | 0.87 | 1.06 | 82% |
| Annual Report Gross Expense Ratio | 1.08 | 1.06 | 102% |
| Fund Existence | 9 years | 11 years | - |
| Gain YTD | 7.212 | 8.175 | 88% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 250 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118M | 204B | 0% |
| Annual Yield % from dividends | 0.26 | 0.76 | 35% |
| Returns for 1 year | -4.23 | 3.78 | -112% |
| Returns for 3 years | 34.55 | 27.15 | 127% |
| Returns for 5 years | 45.15 | 40.82 | 111% |
| Returns for 10 years | N/A | 66.81 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DTCAX | 20.51 | 0.08 | +0.39% |
| BNY Mellon Sust US Equity A | |||
| MSVMX | 6.15 | N/A | N/A |
| Morgan Stanley Vitality Portfolio C | |||
| UOPSX | 93.08 | N/A | N/A |
| ProFunds UltraNASDAQ-100 Svc | |||
| VSFSX | 24.70 | -0.05 | -0.20% |
| Federated Hermes Clover Small Value R6 | |||
| JFNCX | 68.22 | -0.15 | -0.22% |
| Janus Henderson Global Life Sciences C | |||